Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
fzvyKrrHhv0gy5Ff
Listen
